Precision Medicine in Lung Cancer Screening: A Paradigm Shift in Early Detection—Precision Screening for Lung Cancer
Lung cancer remains the leading cause of cancer-related mortality globally, largely due to late-stage diagnoses. While low-dose computed tomography (LDCT) has improved early detection and reduced mortality in high-risk populations, traditional screening strategies often adopt a one-size-fits-all app...
Saved in:
| Main Authors: | Hsin-Hung Chen, Yun-Ju Wu, Fu-Zong Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/12/1562 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer
by: Laura R. Moffitt, et al.
Published: (2024-12-01) -
Identification and Drug Screening of Single Cells from Human Tumors on Semiconductor Chip for Cancer Precision Medicine
by: Wenhao Hui, et al.
Published: (2025-07-01) -
Precision medicine research progress based on colorectal cancer organoids
by: Xiyou Pang, et al.
Published: (2025-06-01) -
Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario
by: Flavia A. Duarte, et al.
Published: (2022-12-01) -
Organoid‐Guided Precision Medicine: From Bench to Bedside
by: Boqiang Tao, et al.
Published: (2025-05-01)